cesarean. Complications of anesthesia during labor and delivery
Conditions
Interventions
Intervention 1: Ropivacaine group: Ropivacaine 1%( 15mg) ) (manufactured by Dei Fratelli Societa Di Eserciozio SpA C & Molteni L, Italy) will be injected during surgery. Intervention 2: Bupivacaine g
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Term pregnancy (over 37 and less than 42 weeks) Elective cesarean section 20-40 years Weight between 65 and 95 kg Height between 155 and 175 cm ASA class I,II
Exclusion criteria
Exclusion criteria: Preterm and post term Abnormalities and problems of placenta or fetus Allergy to local anesthetics Spinal anesthesia contraindications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor block duration. Timepoint: Every 5 minutes in the first 32 minutes and then at 12-minute intervals until the end of surgery. Method of measurement: Modified bromage scale.;?Sensory block duration. Timepoint: Every 5 minutes in the first 32 minutes and then at 12-minute intervals until the end of surgery. Method of measurement: pin prick. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Every 5 minutes before injection until delivery and then every 15 minutes until discharge from the recovery room. Method of measurement: Non-invasive Blood Pressure (NIBP).;Heart rate. Timepoint: Every 5 minutes before injection until delivery and then every 15 minutes until discharge from the recovery room. Method of measurement: ECG.;Analgesia. Timepoint: In the beginning and end of surgery and, when discharging from recovery room. Method of measurement: Visual analogues Scale.;Postoperative Clinical complications. Timepoint: Until 24 hours after discharge from the recovery room. Method of measurement: Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRaziyeh Homayoon
Ahvaz University of Medical Sciences
Outcome results
None listed